B6N;129(B6J)-Htttm1.1Ics/Ics

Status

Available to order

EMMA IDEM:16162
Citation informationRRID:IMSR_EM:16162 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6N;129(B6J)-Htttm1.1Ics/Ics
Alternative nameHtttm1.1Ics/Ics
Strain typeTargeted Mutant Strains : Point mutation
Allele/Transgene symbolHtttm1.1Ics
Gene/Transgene symbolHtt

Information from provider

ProviderSandrine Humbert
Provider affiliationUniversité Grenoble Alpes, Grenoble Institut des Neurosciences (GIN) – INSERM U1216
Genetic informationNucleotide substitutions (AGC to GCC) result in the amino acid substitution of alanine for serine at position 421 (S421A); cre-mediated recombination removed the selection cassette.
Phenotypic informationHomozygous:
N/A

Heterozygous:
N/A
Breeding history75% C57BL/6N; the line was backcrossed 1 time with C57BL/6J mice and two times with C57BL/6NTac mice (C57BL/6J 12.5%, 129/SvPas 12.55%, C57BL/6NTac 75%).
References
  • Unraveling the Role of Huntingtin in Breast Cancer Metastasis.;Thion Morgane S, McGuire John R, Sousa Cristovao M, Fuhrmann Laetitia, Fitamant Julien, Leboucher Sophie, Vacher Sophie, du Montcel Sophie Tezenas, Bièche Ivan, Bernet Agnès, Mehlen Patrick, Vincent-Salomon Anne, Humbert Sandrine, ;2015;Journal of the National Cancer Institute;107;; 26293574
Homozygous fertilenot known
Homozygous viablenot known
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreICS, Institut Clinique de la Souris, Illkirch-Graffenstaden, France

Disease and phenotype information

IMPC phenotypes (gene matching)
  • increased grip strength / IMPC
  • preweaning lethality, complete penetrance / IMPC
  • embryonic lethality prior to organogenesis / IMPC

Literature references

  • Unraveling the Role of Huntingtin in Breast Cancer Metastasis.;Thion Morgane S, McGuire John R, Sousa Cristovao M, Fuhrmann Laetitia, Fitamant Julien, Leboucher Sophie, Vacher Sophie, du Montcel Sophie Tezenas, Bièche Ivan, Bernet Agnès, Mehlen Patrick, Vincent-Salomon Anne, Humbert Sandrine, ;2015;Journal of the National Cancer Institute;107;; 26293574

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).